Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseases.
30 employees · est. 2014 · Gaithersburg, United States
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of immune resistance.
14 employees · est. 2019 · Houston, United States
Georgiamune Inc. is the older company (2014 vs 2019).
Side-by-Side Comparison
| Metric | Georgiamune Inc. | ImmunoGenesis, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2019 |
| Headquarters | ||
| Headquarters | Gaithersburg, United States | Houston, United States |
| Employees | ||
| Employees | 30 | 14 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series Unknown |
| Total Funding | ||
| Total Funding | $75.00M | $28.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Reprogramming Immune Responses, Drug Design and Development, Preclinical Research, Pipeline Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Oncologists, Immunologists, Patients with Cancer, Patients with Autoimmune Diseases, Biopharmaceutical Companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Immune Signaling Pathways, Clinical Stage, Cancer Treatment, Autoimmune Diseases, Immune Therapeutics, Scientific Discovery, Reprogramming Immune System, Disease Fighting, Immune Balance, Biopharmaceuticals | Immuno-oncology, Biopharmaceutical, Drug Development, Immune Resistance, Immune-excluded Tumors, Immunotherapy, Clinical-stage, Immune Response, Tumor Pathology, Cancer Treatment, Immune System, Therapy Development |
| Website | ||
| Website | georgiamune.com | immunogenesis.com |
About Georgiamune Inc.
Georgiamune Inc., founded in 2014, operates at the intersection of biotechnology, health care, and wellness. This U.S.-based clinical-stage immunotherapeutic biotechnology firm is driving innovation by reprogramming immune signaling pathways, a strategy aimed at redefining immune system responses to...
About ImmunoGenesis, Inc.
ImmunoGenesis, Inc. is a clinical-stage immuno-oncology biopharmaceutical company focused on re-envisioning the treatment of "cold" tumors, particularly immune-excluded tumors. These tumors, which account for over half of all cancers, are resistant to current immunotherapies due to mechanisms that s...
We will tell you when either one moves
BounceWatch watches Georgiamune Inc. and ImmunoGenesis, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Georgiamune Inc. and ImmunoGenesis, Inc. — by email.
Frequently Asked Questions
Compare Georgiamune Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Georgiamune Inc. on 9 Jun 2026, and ImmunoGenesis, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.